An Academic Community Hospital Experience Using Commercially Available Molecular Testing in the Management of Indeterminate Thyroid Nodules
The eJournal is an online pathology journal club that reviews current articles from a peer-reviewed cytopathology Journal.
Participants will be able to review the journal article, commentary and webinar from the contributing author. This is a great self-assessment, teaching and continuing education tool.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Discuss the role of molecular testing as a tool for stratifying the risk of malignancy of cytologically indeterminate thyroid nodules
- Evaluate utilization practices of commercially available molecular tests for cytologically indeterminate thyroid nodules in an academic community hospital setting
- Reflect on the limitations of molecular testing in cytologically indeterminate thyroid nodules
- Reflect on the limitations of studies on outcomes of molecular testing in cytologically indeterminate thyroid nodules
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Rachel Jug, MB BCh BAO
Durham, North Carolina
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Continuing Certification (CC) process. Earn up to 1.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 1.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 1 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the presentation date.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 1.00 CMLE
- 1.00 Florida Credits
- 1.00 MOC II
- 1.00 Participant